Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenobamate Adjunctive Therapy in Partial Onset Seizures
NCT04557085Phase 3Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Mar 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of cenobamate in focal onset seizure, sponsored by SK Life Science, Inc.. Started Mar 2021; status: completed.
02
Drugs
cenobamate
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT04557085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04557085.